FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2920739957> ?p ?o ?g. }

• W2920739957 endingPage "436" @default.
• W2920739957 startingPage "430" @default.
• W2920739957 abstract "Purpose: To assess the oncologic impact of adjuvant endocavitary instillation after kidney-sparing surgery (KSS) in the treatment of upper tract urothelial carcinoma (UTUC). Methods: A meta-analysis of the available literature was performed using PUBMED and MEDLINE on June 2018. No time or language restrictions were applied. All included participants were substratified into 2 groups: Ta/T1 UTUC and upper tract (UT) carcinoma in situ. Subjects with higher stage disease, involvement of the bladder, or urethra were excluded. Predefined endpoints of interest were rates of cytology response, UT recurrence, UT progression, cancer-specific survival, and overall survival. Results: Overall, 27 eligible reports for a total of 438 patients were identified and 18 studies included for quantitative analyses. All included reports were nonrandomized observational case series. Among studies that reported on UT recurrence, 154 (35%) patients developed UT recurrence during a median follow-up of 30 months. The overall pooled estimates for adjuvant instillations in Ta-T1 patients were 40% for UT recurrence, 94% for cancer-specific survival, and 71% for OS. Subanalyses stratified by regimen used and instillation approach did not show any significant differences. In patients with UT carcinoma in situ treated with BCG, the pooled estimates for cytology response, UT recurrence, and progression were 84%, 34%, and 16%, respectively. Similarly, comparison between instillation approaches did not show any significant differences. Conclusions: In this meta-analysis of presumed nonmuscle invasive patients treated with kidney-sparing surgery, endocavitary instillations for noninvasive UTUC, did not reveal any differences between the regimens and instillations approaches. Patients with Ta-T1 UTUC had an UT recurrence rate comparable to that reported in the literature for nontreated patients. To date, the efficacy of endocavitary instillations in UTUC remains to be demonstrated. Upcoming novel drugs promise to change this paradigm." @default.
• W2920739957 created "2019-03-11" @default.
• W2920739957 creator A5001883861 @default.
• W2920739957 creator A5011013432 @default.
• W2920739957 creator A5024662180 @default.
• W2920739957 creator A5030019301 @default.
• W2920739957 creator A5044228660 @default.
• W2920739957 creator A5048604566 @default.
• W2920739957 creator A5052536331 @default.
• W2920739957 creator A5064914239 @default.
• W2920739957 creator A5065912887 @default.
• W2920739957 creator A5069476166 @default.
• W2920739957 date "2019-07-01" @default.
• W2920739957 modified "2023-10-18" @default.
• W2920739957 title "Endocavitary treatment for upper tract urothelial carcinoma: A meta-analysis of the current literature" @default.
• W2920739957 cites W1537050408 @default.
• W2920739957 cites W1608896854 @default.
• W2920739957 cites W1827138708 @default.
• W2920739957 cites W1966345283 @default.
• W2920739957 cites W1970615565 @default.
• W2920739957 cites W1970810597 @default.
• W2920739957 cites W1975677927 @default.
• W2920739957 cites W1992222476 @default.
• W2920739957 cites W1997259249 @default.
• W2920739957 cites W2020308757 @default.
• W2920739957 cites W2032637099 @default.
• W2920739957 cites W2038111129 @default.
• W2920739957 cites W2042325212 @default.
• W2920739957 cites W2043319711 @default.
• W2920739957 cites W2054718044 @default.
• W2920739957 cites W2054950242 @default.
• W2920739957 cites W2055636200 @default.
• W2920739957 cites W2061934830 @default.
• W2920739957 cites W2063349142 @default.
• W2920739957 cites W2064781183 @default.
• W2920739957 cites W206565744 @default.
• W2920739957 cites W2075082971 @default.
• W2920739957 cites W2085833972 @default.
• W2920739957 cites W2092025407 @default.
• W2920739957 cites W2095814212 @default.
• W2920739957 cites W2105260028 @default.
• W2920739957 cites W2107328434 @default.
• W2920739957 cites W2111125544 @default.
• W2920739957 cites W2113509715 @default.
• W2920739957 cites W2117653225 @default.
• W2920739957 cites W2119144996 @default.
• W2920739957 cites W2133564174 @default.
• W2920739957 cites W2135674005 @default.
• W2920739957 cites W2142084667 @default.
• W2920739957 cites W2146187039 @default.
• W2920739957 cites W2159780218 @default.
• W2920739957 cites W2165027975 @default.
• W2920739957 cites W2400915417 @default.
• W2920739957 cites W2406041310 @default.
• W2920739957 cites W2468669805 @default.
• W2920739957 cites W2478136527 @default.
• W2920739957 cites W2517588643 @default.
• W2920739957 cites W2571043211 @default.
• W2920739957 cites W2781525129 @default.
• W2920739957 cites W2783371713 @default.
• W2920739957 cites W2788468196 @default.
• W2920739957 cites W2790565211 @default.
• W2920739957 cites W2795755501 @default.
• W2920739957 cites W2916183155 @default.
• W2920739957 cites W3022903699 @default.
• W2920739957 cites W4249552371 @default.
• W2920739957 doi "https://doi.org/10.1016/j.urolonc.2019.02.004" @default.
• W2920739957 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30846387" @default.
• W2920739957 hasPublicationYear "2019" @default.
• W2920739957 type Work @default.
• W2920739957 sameAs 2920739957 @default.
• W2920739957 citedByCount "49" @default.
• W2920739957 countsByYear W29207399572019 @default.
• W2920739957 countsByYear W29207399572020 @default.
• W2920739957 countsByYear W29207399572021 @default.
• W2920739957 countsByYear W29207399572022 @default.
• W2920739957 countsByYear W29207399572023 @default.
• W2920739957 crossrefType "journal-article" @default.
• W2920739957 hasAuthorship W2920739957A5001883861 @default.
• W2920739957 hasAuthorship W2920739957A5011013432 @default.
• W2920739957 hasAuthorship W2920739957A5024662180 @default.
• W2920739957 hasAuthorship W2920739957A5030019301 @default.
• W2920739957 hasAuthorship W2920739957A5044228660 @default.
• W2920739957 hasAuthorship W2920739957A5048604566 @default.
• W2920739957 hasAuthorship W2920739957A5052536331 @default.
• W2920739957 hasAuthorship W2920739957A5064914239 @default.
• W2920739957 hasAuthorship W2920739957A5065912887 @default.
• W2920739957 hasAuthorship W2920739957A5069476166 @default.
• W2920739957 hasConcept C121608353 @default.
• W2920739957 hasConcept C126322002 @default.
• W2920739957 hasConcept C126894567 @default.
• W2920739957 hasConcept C141071460 @default.
• W2920739957 hasConcept C143998085 @default.
• W2920739957 hasConcept C146357865 @default.
• W2920739957 hasConcept C151730666 @default.
• W2920739957 hasConcept C2777546739 @default.
• W2920739957 hasConcept C2777661416 @default.
• W2920739957 hasConcept C2777863537 @default.

• next